Issues on the horizon of normal saline intravenous infusion in critical care medicine

Jasen F. Saad , Fawzy A. Saad

Exploration of Medicine ›› 2026, Vol. 7 ›› Issue (1) : 1001411

PDF (2175KB)
Exploration of Medicine ›› 2026, Vol. 7 ›› Issue (1) :1001411 DOI: 10.37349/emed.2026.1001411
Review
research-article
Issues on the horizon of normal saline intravenous infusion in critical care medicine
Author information +
History +
PDF (2175KB)

Abstract

Recent studies argue that other physiological solutions are superior to normal saline, which is due to their physiological features, better outcomes in critical care, and lower risk of hyperchloremia and acidosis; nonetheless, it is still a mystery how normal saline has dominated the field of fluid therapy worldwide. Moreover, there is an ongoing debate on whether harm to human health may limit its spread in the future. Additionally, new evidence revealed some of the deleterious effects of normal saline, including coagulopathy, metabolic acidosis, acute kidney injury (AKI), and higher mortality in ICU. The predominant cause for these outcomes appears to be the excess chloride concentration of normal saline relative to plasma. Therefore, it appears relevant to suggest that a normal saline solution should be normalized to that of human serum to overcome these pitfalls. An ideal normal saline solution shall be similar to human serum in its pH, osmolarity, and content of sodium, chloride, and essential minerals.

Keywords

normal saline / acidic saline / balanced crystalloids / acidosis / hyperchloremia / diabetic acidosis / myalgia / hyperalgesia

Cite this article

Download citation ▾
Jasen F. Saad, Fawzy A. Saad. Issues on the horizon of normal saline intravenous infusion in critical care medicine. Exploration of Medicine, 2026, 7 (1) : 1001411 DOI:10.37349/emed.2026.1001411

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Reddi BA. Why is saline so acidic (and does it really matter?). Int J Med Sci. 2013; 10: 747-50.

[2]

Blumberg N, Cholette JM, Pietropaoli AP, Phipps R, Spinelli SL, Eaton MP, et al. 0.9% NaCl (Normal Saline) - Perhaps not so normal after all? Transfus Apher Sci. 2018; 57: 127-31.

[3]

Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr. 2008; 27: 179-88.

[4]

Li H, Sun SR, Yap JQ, Chen JH, Qian Q. 0.9% saline is neither normal nor physiological. J Zhejiang Univ Sci B. 2016; 17: 181-7.

[5]

Rasouli M. Why 0.9% saline is not normal. Pediatr Nephrol. 2019; 34: 1301-2.

[6]

Rasouli M. Basic concepts and practical equations on osmolality: Biochemical approach. Clin Biochem. 2016; 49: 936-41.

[7]

Weinberg L, Collins N, Van Mourik K, Tan C, Bellomo R. Plasma-Lyte 148: A clinical review. World J Crit Care Med. 2016; 5: 235-50.

[8]

Han K, Lee JY, Shin JE, Kim CH. Positional alcohol nystagmus and serum osmolality: New insights into dizziness associated with acute alcohol intoxication. Med Hypotheses. 2020; 138: 109606.

[9]

Juncos LA, Connor MJ. Physiologic Solutions are Superior to Normal Saline in Critically Ill Patients: PRO. Kidney360. 2025; 6: 1270-2.

[10]

Santi M, Lava SA, Camozzi P, Giannini O, Milani GP, Simonetti GD, et al. The great fluid debate: saline or so-called “balanced” salt solutions? Ital J Pediatr. 2015; 41: 47.

[11]

Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010; 5 Suppl 1: S23-30.

[12]

Hamroun A, Pekar JD, Lionet A, Ghulam A, Maboudou P, Mercier A, et al. Ionized calcium: analytical challenges and clinical relevance. J Lab Precis Med. 2020; 5: 22.

[13]

Höffken B, Parkinson DK, Storms P, Radde IC. Effects of alterations of blood pH on calcium ion activity in rat plasma. Clin Orthop Relat Res. 1971; 78: 30-9.

[14]

Gaiter AM, Bonfant G, Manes M, Belfanti P, Alloatti S. Relation between blood pH and ionized calcium during acute metabolic alteration of the acid-base balance in vivo. Scand J Clin Lab Invest. 1997; 57: 317-23.

[15]

Sprague SM, Krieger NS, Bushinsky DA. Greater inhibition of in vitro bone mineralization with metabolic than respiratory acidosis. Kidney Int. 1994; 46: 1199-206.

[16]

Ori Y, Lee SG, Krieger NS, Bushinsky DA. Osteoblastic intracellular pH and calcium in metabolic and respiratory acidosis. Kidney Int. 1995; 47: 1790-6.

[17]

Hinkle JE, Cooperman LH. Serum ionized calcium changes following citrated blood transfusion in anaesthetized man. Br J Anaesth. 1971; 43: 1108-12.

[18]

Bunker JP. Metabolic effects of blood transfusion. Anesthesiology. 1966; 27: 446-55.

[19]

Semler MW, Rice TW. Saline Is Not the First Choice for Crystalloid Resuscitation Fluids. Crit Care Med. 2016; 44: 1541-4.

[20]

McGartland C, Robson PJ, Murray L, Cran G, Savage MJ, Watkins D, et al. Carbonated soft drink consumption and bone mineral density in adolescence: the Northern Ireland Young Hearts project. J Bone Miner Res. 2003; 18: 1563-9.

[21]

Ma D, Jones G. Soft drink and milk consumption, physical activity, bone mass, and upper limb fractures in children: a population-based case-control study. Calcif Tissue Int. 2004; 75: 286-91.

[22]

Libuda L, Alexy U, Remer T, Stehle P, Schoenau E, Kersting M. Association between long-term consumption of soft drinks and variables of bone modeling and remodeling in a sample of healthy German children and adolescents. Am J Clin Nutr. 2008; 88: 1670-7.

[23]

Høstmark AT, Søgaard AJ, Alvær K, Meyer HE. The oslo health study: a dietary index estimating frequent intake of soft drinks and rare intake of fruit and vegetables is negatively associated with bone mineral density. J Osteoporos. 2011; 2011: 102686.

[24]

Nikolić R, Kaličanin B, Krstić N. The release of zinc, copper, lead, and cadmium from the mineral tissue of teeth under the influence of soft drinks and sour-tasting food. Connect Tissue Res. 2012; 53: 229-35.

[25]

Chen L, Liu R, Zhao Y, Shi Z. High Consumption of Soft Drinks Is Associated with an Increased Risk of Fracture: A 7-Year Follow-Up Study. Nutrients. 2020; 12: 530.

[26]

Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve. 2001; 24: 37-46.

[27]

Skyda DA, King EW, Sluka KA. Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline. Pain. 2002; 98: 69-78.

[28]

Radhakrishnan R, Bement MK, Skyba D, Sluka KA, Kehl LJ. Models of muscle pain: carrageenan model and acidic saline model. Curr Protoc Pharmacol. 2004; Chapter 5: Unit 5.35.

[29]

Da Silva LF, Desantana JM, Sluka KA. Activation of NMDA receptors in the brainstem, rostral ventromedial medulla, and nucleus reticularis gigantocellularis mediates mechanical hyperalgesia produced by repeated intramuscular injections of acidic saline in rats. J Pain. 2010; 11: 378-87.

[30]

Sluka KA, O’Donnell JM, Danielson J, Rasmussen LA. Regular physical activity prevents development of chronic pain and activation of central neurons. J Appl Physiol (1985). 2013; 114: 725-33.

[31]

Louca S, Ernberg M, Christidis N. Influence of intramuscular granisetron on experimentally induced muscle pain by acidic saline. J Oral Rehabil. 2013; 40: 403-12.

[32]

Sugimura N, Ikeuchi M, Izumi M, Kawano T, Aso K, Kato T, et al. Repeated intra-articular injections of acidic saline produce long-lasting joint pain and widespread hyperalgesia. Eur J Pain. 2015; 19: 629-38.

[33]

Louca Jounger S, Eriksson N, Lindskog H, Oscarsson A, Simonsson V, Ernberg M, et al. Repeated buffered acidic saline infusion in the human masseter muscle as a putative experimental pain model. Sci Rep. 2019; 9: 15474.

[34]

Castrillon EE, Cairns B, List T, Svensson P, Ernberg M. Acidic saline-induced pain as a model for experimental masseter myalgia in healthy subjects. Eur J Pain. 2013; 17: 1438-46.

[35]

Sharma NK, Ryals JM, Liu H, Liu W, Wright DE. Acidic saline-induced primary and secondary mechanical hyperalgesia in mice. J Pain. 2009; 10: 1231-41.

[36]

Jasper LL, MacNeil BJ. Diverse sensory inputs permit priming in the acidic saline model of hyperalgesia. Eur J Pain. 2012; 16: 966-73.

[37]

Wang K, Luo Y, Asaki T, Graven-Nielsen T, Cairns BE, Arendt-Nielsen T, et al. Acid-induced experimental muscle pain and hyperalgesia with single and repeated infusion in human forearm. Scand J Pain. 2017; 17: 260-6.

[38]

Asaki T, Wang K, Luo Y, Arendt-Nielsen T, Graven-Nielsen T, Arendt-Nielsen L. Acid-induced experimental knee pain and hyperalgesia in healthy humans. Exp Brain Res. 2018; 236: 587-98.

[39]

Choi GJ, Kang H, Lee OH, Ahn EJ, White FA, Cho YJ, et al. Effectiveness of maturity of Rubus occidentalis on hyperalgesia induced by acidic saline injection in rats. BMC Complement Med Ther. 2022; 22: 12.

[40]

Chen L, Liu C, Zhang Z, Zhang Y, Feng X. Effects of normal saline versus lactated Ringer's solution on organ function and inflammatory responses to heatstroke in rats. J Intensive Care. 2024; 12: 39.

[41]

Stellwagen E, Babul J. Stabilization of the globular structure of ferricytochrome c by chloride in acidic solvents. Biochemistry. 1975; 14: 5135-40.

[42]

Tsuang FY, Wu YL, Chan KC, Lee CT, Wu CY. An Exploratory Randomized Controlled Trial of 0.9% Saline Versus Lactated Ringer’s Solution on Intraoperative Metabolism Among Patients Undergoing Lumbar Spinal Surgery. Int J Med Sci. 2026; 23: 1002-14.

[43]

Jamison A, Mohamed A, Chedester C, Klindworth K, Hamarshi M, Sembroski E. Lactated Ringer’s versus normal saline in the management of acute diabetic ketoacidosis (RINSE-DKA). Pharmacotherapy. 2024; 44: 623-30.

[44]

Brailoiu GC, Deliu E, Altmann JB, Chitravanshi V, Brailoiu E. Evidence for role of acid-sensing ion channels in nucleus ambiguus neurons: essential differences in anesthetized versus awake rats. J Comp Physiol B. 2014; 184: 753-61.

[45]

Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012; 255: 821-9.

[46]

Murasawa H, Kobayashi H, Yasuda SI, Saeki K, Domon Y, Arakawa N, et al. Anxiolytic-like effects of mirogabalin, a novel ligand for α2δ ligand of voltage-gated calcium channels, in rats repeatedly injected with acidic saline intramuscularly, as an experimental model of fibromyalgia. Pharmacol Rep. 2020; 72: 571-9.

[47]

Murasawa H, Pawlak A, Kobayashi H, Saeki K, Yasuda SI, Kitano Y. Mirogabalin, a novel ligand for α2δ subunit of voltage-gated calcium channels, improves cognitive impairments in repeated intramuscular acidic saline injection model rats, an experimental model of fibromyalgia. Biomed Pharmacother. 2021; 139: 111647.

[48]

Newman MR, Benoit DSW. In Vivo Translation of Peptide-Targeted Drug Delivery Systems Discovered by Phage Display. Bioconjug Chem. 2018; 29: 2161-9.

[49]

Sluka KA, Price MP, Breese NM, Stucky CL, Wemmie JA, Welsh MJ. Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain. 2003; 106: 229-39.

[50]

Hung C, Chin Y, Fong Y, Lee C, Han D, Lin J, et al. Acidosis-related pain and its receptors as targets for chronic pain. Pharmacol Ther. 2023; 247: 108444.

[51]

Chow LH, Ho CM, Yang YC, Lee TY, Lui PW. Vecuronium dissolved in normal saline exaggerates pain on intravenous injection. Zhonghua Yi Xue Za Zhi (Taipei). 1995; 55: 315-8.

[52]

Birklein F, Weber M, Ernst M, Riedl B, Neundörfer B, Handwerker HO. Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS). Pain. 2000; 87: 227-34.

[53]

Janjua NK, Siddiqa A, Yaqub A, Sabahat S, Qureshi R, ul Haque S. Spectrophotometric analysis of flavonoid-DNA binding interactions at physiological conditions. Spectrochim Acta A Mol Biomol Spectrosc. 2009; 74: 1135-7.

[54]

Temerk Y, Ibrahim M, Ibrahim H, Kotb M. Interactions of an anticancer drug Formestane with single and double stranded DNA at physiological conditions. J Photochem Photobiol B. 2015; 149: 27-36.

[55]

Hopkins E, Sanvictores T, Sharma S. Physiology, Acid Base Balance. Treasure Island (FL): StatPearls Publishing; 2022.

[56]

Rodríguez-Villar S, Kraut JA, Arévalo-Serrano J, Sakka SG, Harris C, Awad I, et al.; Acid-Base Working Group. Systemic acidemia impairs cardiac function in critically Ill patients. EClinicalMedicine. 2021; 37: 100956.

[57]

Reusch HP, Reusch R, Rosskopf D, Siffert W, Mann JF, Luft FC. Na+/H+ exchange in human lymphocytes and platelets in chronic and subacute metabolic acidosis. J Clin Invest. 1993; 92: 858-65.

[58]

Nakamura M, Ikeda K, Uezono S. Metabolic acidemia due to saline absorption during transurethral and transcervical surgery: a report of 2 cases. BMC Anesthesiol. 2024; 24: 62.

[59]

Barker ME. 0.9% saline induced hyperchloremic acidosis. J Trauma Nurs. 2015; 22: 111-6.

[60]

Hoorn EJ. Intravenous fluids: balancing solutions. J Nephrol. 2017; 30: 485-92.

[61]

Semler MW, Kellum JA. Balanced Crystalloid Solutions. Am J Respir Crit Care Med. 2019; 199: 952-60.

[62]

Messina N, Anderson Z, Saravis L, Jimenez G, Plowman K, Harrington D. Revisiting Diabetic Ketoacidosis (DKA) Fluid Management: Should Normal Saline Be Used? Cureus. 2025; 17: e77739.

[63]

DiNicolantonio JJ, O’Keefe J. Low-grade metabolic acidosis as a driver of chronic disease: a 21st century public health crisis. Open Heart. 2021; 8: e001730.

[64]

Yang L, Hu X, Mo Y. Acidosis promotes tumorigenesis by activating AKT/NF-κB signaling. Cancer Metastasis Rev. 2019; 38: 179-88.

[65]

Lenert ME, Green AR, Merriwether EN, Burton MD. B-cell and plasma cell activation in a mouse model of chronic muscle pain. Neurobiol Pain. 2024; 16: 100169.

[66]

Mason TG, Kraut JA. Treatment of Acidified Blood Using Reduced Osmolarity Mixed-Base Solutions. Front Physiol. 2016; 7: 625.

[67]

Hammond NE, Zampieri FG, Di Tanna GL, Garside T, Adigbli D, Cavalcanti AB, et al. Balanced Crystalloids versus Saline in Critically Ill Adults - A Systematic Review with Meta-Analysis. NEJM Evid. 2022; 1: EVIDoa2100010.

[68]

Hayes W. Ab-normal saline in abnormal kidney function: risks and alternatives. Pediatr Nephrol. 2019; 34: 1191-9.

[69]

Feuerstein G, Boonyaviroj P, Gutman Y. The effect of saline loading on blood pressure and catecholamine secretion in the rat and the cat. Eur J Pharmacol. 1979; 54: 373-82.

[70]

Luft FC, Rankin LI, Bloch R, Willis LR, Fineberg NS, Weinberger MH. The effects of rapid saline infusion on sodium excretion, renal function, and blood pressure at different sodium intakes in man. Am J Kidney Dis. 1983; 2: 464-70.

[71]

Wu J, Nie J, Wang Y, Zhang Y, Wu D. Relationship between saline infusion and blood pressure variability in non-critically patients with hypertension: A retrospective study. Medicine (Baltimore). 2020; 99: e21468.

[72]

Kim GH. Primary Role of the Kidney in Pathogenesis of Hypertension. Life (Basel). 2024; 14: 119.

[73]

Saad FA. Novel insights into the complex architecture of osteoporosis molecular genetics. Ann N Y Acad Sci. 2020; 1462: 37-52.

[74]

Yu E, Sharma S. Physiology, Calcium. Treasure Island (FL): StatPearls Publishing; 2023.

[75]

Dekker SE, Sillesen M, Bambakidis T, Jin G, Liu B, Boer C, et al. Normal saline influences coagulation and endothelial function after traumatic brain injury and hemorrhagic shock in pigs. Surgery. 2014; 156: 556-63.

[76]

Cheng H, Wei S, Wei L, Verkhratsky A. Calcium signaling in physiology and pathophysiology. Acta Pharmacol Sin. 2006; 27: 767-72.

[77]

Allgrove J. Physiology of Calcium, Phosphate, Magnesium and Vitamin D. Endocr Dev. 2015; 28: 7-32.

[78]

Pinto MC, Kihara AH, Goulart VA, Tonelli FM, Gomes KN, Ulrich H, et al. Calcium signaling and cell proliferation. Cell Signal. 2015; 27: 2139-49.

[79]

Klein GL. The Role of Calcium in Inflammation-Associated Bone Resorption. Biomolecules. 2018; 8: 69.

[80]

Talotta R, Rucci F, Scaglione F. Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis. Reumatologia. 2020; 58: 297-311.

[81]

Choi GJ, Kang H, Kim WJ, Baek CW, Jung YH, Woo YC, et al. Rubus occidentalis alleviates hyperalgesia induced by repeated intramuscular injection of acidic saline in rats. BMC Complement Altern Med. 2016; 16: 202.

[82]

Costa DM, da Silva RP, da Cruz-Filho J, de Oliveira Santos T, Dos Anjos-Santos HC, de Lucca W Jr, et al. Adrenalectomy attenuates hyperalgesia but does not regulate muscle wasting in a female rat model of fibromyalgia. Clin Exp Pharmacol Physiol. 2024; 51: e13837.

[83]

Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet. 1976; 1: 626-9.

[84]

Russell JA. Osteomalacic myopathy. Muscle Nerve. 1994; 17: 578-80.

[85]

Ho JQ, Abramowitz MK. Clinical Consequences of Metabolic Acidosis-Muscle. Adv Chronic Kidney Dis. 2022; 29: 395-405.

[86]

Thatte HS, Rhee J, Zagarins SE, Treanor PR, Birjiniuk V, Crittenden MD, et al. Acidosis-induced apoptosis in human and porcine heart. Ann Thorac Surg. 2004; 77: 1376-83.

[87]

Orchard CH, McCall E, Kirby MS, Boyett MR. Mechanical alternans during acidosis in ferret heart muscle. Circ Res. 1991; 68: 69-76.

[88]

Poole-Wilson PA. Acidosis and contractility of heart muscle. Ciba Found Symp. 1982; 87: 58-76.

[89]

Frasch MG, Giussani DA. Heart during acidosis: Etiology and early detection of cardiac dysfunction. EClinicalMedicine. 2021; 37: 100994.

[90]

Ozawa H, Homma Y, Arisawa H, Fukuuchi F, Handa S. Severe metabolic acidosis and heart failure due to thiamine deficiency. Nutrition. 2001; 17: 351-2.

[91]

Blanc P, Henriette K, Boussuges A. Severe metabolic acidosis and heart failure due to thiamine deficiency. Nutrition. 2002; 18: 118.

[92]

Miller JD, Hemauer SJ, Smith CA, Stickland MK, Dempsey JA. Expiratory threshold loading impairs cardiovascular function in health and chronic heart failure during submaximal exercise. J Appl Physiol (1985). 2006; 101: 213-27.

[93]

Oliveira LR, de Melo VU, Macedo FN, Barreto AS, Badaue-Passos D Jr, Viana dos Santos MR, et al. Induction of chronic non-inflammatory widespread pain increases cardiac sympathetic modulation in rats. Auton Neurosci. 2012; 167: 45-9.

[94]

Li M, Inoue K, Branigan D, Kratzer E, Hansen JC, Chen JW, et al. Acid-sensing ion channels in acidosis-induced injury of human brain neurons. J Cereb Blood Flow Metab. 2010; 30: 1247-60.

[95]

Goldman SA, Pulsinelli WA, Clarke WY, Kraig RP, Plum F. The effects of extracellular acidosis on neurons and glia in vitro. J Cereb Blood Flow Metab. 1989; 9: 471-7.

[96]

Ying W, Han SK, Miller JW, Swanson RA. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J Neurochem. 1999; 73: 1549-56.

[97]

Schmitz C, Bültmann E, Gube M, Korr H. Neuron loss in the mouse hippocampus following prenatal injection of tritiated thymidine or saline. Int J Dev Neurosci. 1999; 17: 185-90.

[98]

Ding D, Moskowitz SI, Li R, Lee SB, Esteban M, Tomaselli K, et al. Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp Neurol. 2000; 162: 1-12.

[99]

Windle WF, Koenig H, Jensen AV. Histologic study of the brain in experimentally induced acidosis. Arch Neurol Psychiatry. 1946; 56: 428-33.

[100]

Pirchl M, Marksteiner J, Humpel C. Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer’s disease. Neurol Res. 2006; 28: 657-64.

[101]

Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 2015; 163: 1064-78.

[102]

Chi OZ, Hunter C, Liu X, Tan T, Weiss HR. Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity. Pharmacology. 2008; 82: 187-92.

[103]

Li F, Liu X, Su Z, Sun R. Acidosis leads to brain dysfunctions through impairing cortical GABAergic neurons. Biochem Biophys Res Commun. 2011; 410: 775-9.

[104]

Song R, Zhang L, Yang Z, Tian X. Acidosis and alkalosis impair brain functions through weakening spike encoding at cortical GABAergic neurons. J Neurol Sci. 2011; 304: 122-6.

[105]

Huang L, Zhao S, Lu W, Guan S, Zhu Y, Wang J. Acidosis-Induced Dysfunction of Cortical GABAergic Neurons through Astrocyte-Related Excitotoxicity. PLoS One. 2015; 10: e0140324.

[106]

Zhao H, Cai Y, Yang Z, He D, Shen B. Acidosis leads to neurological disorders through overexciting cortical pyramidal neurons. Biochem Biophys Res Commun. 2011; 415: 224-8.

[107]

Guo M, Qiu M, Zeng L, Nie Y, Tang Y, Luo Y, et al. Acidosis induces autophagic cell death through ASIC1-mediated Akt/mTOR signaling in HT22 neurons. Toxicology. 2025; 511: 154045.

[108]

Sugiura T, Bielefeldt K, Gebhart GF. Mouse colon sensory neurons detect extracellular acidosis via TRPV1. Am J Physiol Cell Physiol. 2007; 292: C1768-74.

[109]

Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski MJ, Wisniewski HM. Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer’s beta-amyloid protein precursor in the brain. Brain Res. 1994; 649: 323-8.

[110]

Brewer GJ. Effects of acidosis on the distribution of processing of the beta-amyloid precursor protein in cultured hippocampal neurons. Mol Chem Neuropathol. 1997; 31: 171-86.

[111]

El-Terras A, Soliman MM, Alkhedaide A, Attia HF, Alharthy A, Banaja AE. Carbonated soft drinks induce oxidative stress and alter the expression of certain genes in the brains of Wistar rats. Mol Med Rep. 2016; 13: 3147-54.

[112]

Latta T. Letter from Dr. Latta to the Secretary of the Central Board of Health, London, affording a view of the rationale and results of his practice in the treatment of cholera by aqueous and saline injections. 1832. Int J Epidemiol. 2013; 42: 387-90.

[113]

Fernández-Sarmiento J, Casas-Certain C, Ferro-Jackaman S, Solano-Vargas FH, Domínguez-Rojas , Pilar-Orive FJ. A brief history of crystalloids: the origin of the controversy. Front Pediatr. 2023; 11: 1202805.

[114]

Liu X, Lu M. Normal saline: Past, present, and future. Sci Prog. 2023; 106: 368504231168821.

[115]

Stefanache A, Lungu I, Butnariu I, Calin G, Gutu C, Marcu C, et al. Understanding How Minerals Contribute to Optimal Immune Function. J Immunol Res. 2023; 2023: 3355733.

[116]

Hombrebueno JR, Luo C, Guo L, Chen M, Xu H. Intravitreal Injection of Normal Saline Induces Retinal Degeneration in the C57BL/6J Mouse. Transl Vis Sci Technol. 2014; 3: 3.

[117]

Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med. 2000; 28: 74-8.

[118]

Williams RN, Hj Ibrahim N, Nunes QM, Allison SP, Rowlands BJ, Adrian Robins R, et al. Effect of intravenous infusion of 0.9% saline on neutrophil activation in healthy volunteers. J Organ Dysfunction. 2006; 2:166e72.

[119]

Fenves AZ, Allegretti AS. Physiologic Solutions are Superior to Normal Saline in Critically Ill Patients: CON. Kidney360. 2025; 6: 1273-5.

[120]

Sanghavi SF. Physiologic Solutions are Superior to Normal Saline in Critically Ill Patients: Commentary. Kidney360. 2025; 6: 1276-7.

[121]

Diz JC, Luna-Rojas P, Díaz-Vidal P, Fernández-Vázquez U, Gil-Casado C, Diz-Ferreira E. Effect of Treatment With Balanced Crystalloids Versus Normal Saline on the Mortality of Critically Ill Patients With and Without Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Anesth Analg. 2025; 141: 152-61.

[122]

Waikar SS, Winkelmayer WC. Saving the kidneys by sparing intravenous chloride? JAMA. 2012; 308: 1583-5.

[123]

Luo S, McSweeney KM, Wang T, Bacot SM, Feldman GM, Zhang B. Defining the right diluent for intravenous infusion of therapeutic antibodies. MAbs. 2020; 12: 1685814.

[124]

Ince C, Groeneveld AB. The case for 0.9% NaCl: is the undefendable, defensible? Kidney Int. 2014; 86: 1087-95.

[125]

Mayerhöfer T, Shaw AD, Wiedermann CJ, Joannidis M. Fluids in the ICU: which is the right one? Nephrol Dial Transplant. 2023; 38: 1603-12.

[126]

McIntyre L, Fergusson D, McArdle T, English S, Cook DJ, Fox-Robichaud AE, et al.; Canadian Critical Care Trials Group. A Crossover Trial of Hospital-Wide Lactated Ringer’s Solution versus Normal Saline. N Engl J Med. 2025; 393: 660-70.

[127]

Zampieri FG, Machado FR, Biondi RS, Freitas FGR, Veiga VC, Figueiredo RC, et al.; BaSICS investigators and the BRICNet members. Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA. 2021; 326: 1-12.

[128]

Singhal D, Gupta S, Kumar V. Normal Saline Versus Ringer’s Lactate for Intravenous Fluid Therapy in Children with Diabetic Ketoacidosis: A Randomized Controlled Trial. Indian J Pediatr. 2025; 92: 1181-7.

[129]

Salinero A, Mitzova-Vladinov G. Battle of the Crystalloids in the Operating Room: A Literature Review. J Perianesth Nurs. 2021; 36: 629-37.

[130]

Mikhael B, Steele DJR, Fenves AZ. In Defense of Normal Saline: Our Perspective. Clin J Am Soc Nephrol. 2022; 17: 588-90.

[131]

Self WH, Semler MW, Wanderer JP, Ehrenfeld JM, Byrne DW, Wang L, et al. Saline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial. Trials. 2017; 18: 178.

[132]

Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, et al.; SALT Investigators* and the Pragmatic Critical Care Research Group; SALT Investigators. Balanced Crystalloids versus Saline in the Intensive Care Unit. The SALT Randomized Trial. Am J Respir Crit Care Med. 2017; 195: 1362-72.

[133]

Semler MW, Self WH, Wang L, Byrne DW, Wanderer JP, Ehrenfeld JM, et al.; Isotonic Solutions and Major Adverse Renal Events Trial (SMART) Investigators; Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial. Trials. 2017; 18: 129.

[134]

Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al.; SMART Investigators and the Pragmatic Critical Care Research Group. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018; 378: 829-39.

[135]

Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, et al.; SALT-ED Investigators. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med. 2018; 378: 819-28.

[136]

Brown RM, Wang L, Coston TD, Krishnan NI, Casey JD, Wanderer JP, et al. Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial. Am J Respir Crit Care Med. 2019; 200: 1487-95.

[137]

Lobo DN. Intravenous 0.9% saline and general surgical patients: a problem, not a solution. Ann Surg. 2012; 255: 830-2.

[138]

Stephens R, Mythen M. Optimizing intraoperative fluid therapy. Curr Opin Anaesthesiol. 2003; 16: 385-92.

[139]

Lee J. Plasma volume expanders and intraoperative fluid therapy. Korean J Anesthesiol. 2009; 56: 483-91.

[140]

Bjerregaard LS, Møller-Sørensen H, Hansen KL, Ravn J, Nilsson JC. Using clinical parameters to guide fluid therapy in high-risk thoracic surgery. A retrospective, observational study. BMC Anesthesiol. 2015; 15: 91.

[141]

Langer T, Limuti R, Tommasino C, van Regenmortel N, Duval ELIM, Caironi P, et al. Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side effects. Anaesthesiol Intensive Ther. 2018; 50: 49-58.

[142]

Zawadzki B, Narciso RC, da Hora Passos R. Beyond the saline versus balanced debate: a neuro-systemic framework for fluid therapy in acute brain injury. Intensive Care Med. 2026; 52: 414-5.

PDF (2175KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/